TD Asset Management Inc. Cuts Stock Holdings in Danaher Co. (NYSE:DHR)

TD Asset Management Inc. reduced its stake in Danaher Co. (NYSE:DHR) by 13.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,545,548 shares of the conglomerate’s stock after selling 248,087 shares during the quarter. TD Asset Management Inc. owned approximately 0.21% of Danaher worth $354,781,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Modern Wealth Management LLC increased its position in shares of Danaher by 30.5% during the 4th quarter. Modern Wealth Management LLC now owns 1,087 shares of the conglomerate’s stock valued at $250,000 after purchasing an additional 254 shares during the last quarter. CoreFirst Bank & Trust bought a new stake in Danaher in the fourth quarter worth about $692,000. Napean Trading & Investment Co Singapore PTE Ltd boosted its stake in Danaher by 52.9% in the fourth quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 55,497 shares of the conglomerate’s stock valued at $12,739,000 after acquiring an additional 19,193 shares during the last quarter. Prudential Financial Inc. grew its position in shares of Danaher by 3.2% during the 4th quarter. Prudential Financial Inc. now owns 882,312 shares of the conglomerate’s stock valued at $202,535,000 after acquiring an additional 26,982 shares during the period. Finally, ICW Investment Advisors LLC increased its stake in shares of Danaher by 4.8% during the 4th quarter. ICW Investment Advisors LLC now owns 4,982 shares of the conglomerate’s stock worth $1,144,000 after purchasing an additional 228 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Up 0.8 %

Shares of NYSE:DHR opened at $212.97 on Tuesday. The firm has a fifty day moving average of $216.92 and a 200 day moving average of $238.13. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market capitalization of $152.21 billion, a PE ratio of 40.33, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm posted $2.09 EPS. As a group, research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. Danaher’s dividend payout ratio is 24.24%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. Robert W. Baird dropped their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Wells Fargo & Company cut their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Finally, Citigroup dropped their price target on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Five analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $278.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.